The changes of Lp-PLA2 in patients with gestational diabetes and its clinical significance

Prevalence, Risk Factors, and Fetomaternal Outcomes of Gestational Diabetes Mellitus in Kuwait: A Cross-Sectional Study

(2019) Zainab Groof et al.   Journal of Diabetes Research

Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift

(2019) Christopher J Nolan et al.   Diabetes & Vascular Disease Research

Lipoprotein‐associated phospholipase A2: The story continues

(2019) Fubao Huang et al.   MEDICINAL RESEARCH REVIEWS

Gestational Diabetes Mellitus

(2019) Emily D. Szmuilowicz et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Hyperglycemia During Pregnancy and Long-Term Offspring Outcomes

(2019) Monica E. Bianco et al.   Current Diabetes Reports

Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids

(2018) Laura Jackisch et al.   DIABETOLOGIA

Effect of lipoprotein-associated phospholipase A2 inhibitor on insulin resistance in streptozotocin-induced diabetic pregnant rats

(2018) Guo-Hua Wang et al.   ENDOCRINE JOURNAL

Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients

(2018) Andreana De Mauri et al.   JOURNAL OF NEPHROLOGY

Circulating Betatrophin Levels and Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis

(2017) Fei-Juan Kong et al.   PLoS One

Maternal Gestational Diabetes Mellitus increases placental and foetal lipoprotein-associated Phospholipase A2 which might exert protective functions against oxidative stress

(2017) Carolin Schliefsteiner et al.   Scientific Reports

Activity and distribution of plasma platelet-activating factor acetylhydrolase in women with gestational diabetes mellitus and their neonates

(2016) Qian Gao et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes

(2016) Xiu-hong Lin et al.   Lipids in Health and Disease

Lipoprotein-associated phospholipase A2(Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes

(2016) Paul Canning et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis

(2016) Juan Zhang et al.   YONSEI MEDICAL JOURNAL

Circulating Lp-PLA2 activity correlates with oxidative stress and cytokines in overweight/obese postmenopausal women not using hormone replacement therapy

(2015) Jean Kyung Paik et al.   AGE

Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis

(2015) KK Ryckman et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Lipoprotein-associated phospholipase A2 and AGEs are associated with cardiovascular risk factors in women with history of gestational diabetes mellitus

(2014) Caiyuan Mai et al.   GYNECOLOGICAL ENDOCRINOLOGY

Risk of Adverse Pregnancy Outcomes in Women With Mild Chronic Hypertension Before 20 Weeks of Gestation

(2014) Nana-Ama Ankumah et al.   OBSTETRICS AND GYNECOLOGY

Sequencing of Lp-PLA2-encoding PLA2G7 gene in 2000 Europeans reveals several rare loss-of-function mutations

(2011) K Song et al.   PHARMACOGENOMICS JOURNAL